Cargando…

PLEKHS1: A new molecular marker predicting risk of progression of non-muscle-invasive bladder cancer

Promoter mutations of pleckstrin homology domain-containing S1 (PLEKHS1) are frequent in several cancer types. To evaluate the DNA mutations, the mRNA expression and prognostic value of PLEKHS1 was evaluated in bladder cancer. We investigated DNA mutations and mRNA expression of PLEKHS1 in a first s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pignot, Géraldine, Le Goux, Constance, Vacher, Sophie, Schnitzler, Anne, Radvanyi, François, Allory, Yves, Lallemand, François, Delongchamps, Nicolas Barry, Zerbib, Marc, Terris, Benoit, Damotte, Diane, Bieche, Ivan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733015/ https://www.ncbi.nlm.nih.gov/pubmed/31516565 http://dx.doi.org/10.3892/ol.2019.10706

Ejemplares similares

Assessment of prognostic implication of a panel of oncogenes in bladder cancer and identification of a 3-gene signature associated with recurrence and progression risk in non-muscle-invasive bladder cancer
por: Le Goux, Constance, et al.
Publicado: (2020)

Genomic Instability Signature of Palindromic Non-Coding Somatic Mutations in Bladder Cancer
por: Vacher, Sophie, et al.
Publicado: (2020)

Inhibition of PI3K pathway increases immune infiltrate in muscle-invasive bladder cancer
por: Borcoman, Edith, et al.
Publicado: (2019)

Hedgehog pathway activation in human transitional cell carcinoma of the bladder
por: Pignot, G, et al.
Publicado: (2012)

MiR-190b, the highest up-regulated miRNA in ERα-positive compared to ERα-negative breast tumors, a new biomarker in breast cancers?
por: Cizeron-Clairac, Geraldine, et al.
Publicado: (2015)

High Positive Correlations between ANRIL and p16-CDKN2A/p15-CDKN2B/p14-ARF Gene Cluster Overexpression in Multi-Tumor Types Suggest Deregulated Activation of an ANRIL–ARF Bidirectional Promoter
por: Drak Alsibai, Kinan, et al.
Publicado: (2019)

A prospective multicenter study on bladder cancer: the COBLAnCE cohort
por: Benhamou, Simone, et al.
Publicado: (2016)

Design of a randomized controlled phase III study of dose dense methotrexate, vinblastine, doxorubicin and cisplatin (dd-MVAC) or gemcitabine and cisplatin (GC) as peri-operative chemotherapy for patients with locally advanced transitional cell cancer of the bladder. The French GETUG/AFU V05 VESPER trial
por: Pfister, Christian, et al.
Publicado: (2020)

High AHR expression in breast tumors correlates with expression of genes from several signaling pathways namely inflammation and endogenous tryptophan metabolism
por: Vacher, Sophie, et al.
Publicado: (2018)

PLEKHS1 Over-Expression is Associated with Metastases and Poor Outcomes in Papillary Thyroid Carcinoma
por: Xing, Xiangling, et al.
Publicado: (2020)

Deregulation of Rab and Rab Effector Genes in Bladder Cancer
por: Ho, Joel R., et al.
Publicado: (2012)

Identification of targeted therapy for an aggressive subgroup of muscle-invasive bladder cancers
por: Lebret, Thierry, et al.
Publicado: (2015)

Involvement of the FOXO6 transcriptional factor in breast carcinogenesis
por: Lallemand, François, et al.
Publicado: (2017)

Analysis of the copy number profiles of several tumor samples from the same patient reveals the successive steps in tumorigenesis
por: Letouzé, Eric, et al.
Publicado: (2010)

Analysis of the copy number profiles of several tumor samples from the same patient reveals the successive steps in tumorigenesis
por: Letouzé, Eric, et al.
Publicado: (2010)

Evaluation of gene expression of PLEKHS1, AADAC, and CDKN3 as novel genomic markers in gastric carcinoma
por: Abdel-Tawab, Marwa Sayed, et al.
Publicado: (2022)

Expression analysis of mitotic spindle checkpoint genes in breast carcinoma: role of NDC80/HEC1 in early breast tumorigenicity, and a two-gene signature for aneuploidy
por: Bièche, Ivan, et al.
Publicado: (2011)

Regulatory region mutations of TERT, PLEKHS1 and GPR126 genes as urinary biomarkers in upper tract urothelial carcinomas
por: Xing, Xiangling, et al.
Publicado: (2021)

An essential role for decorin in bladder cancer invasiveness
por: El Behi, Mohamed, et al.
Publicado: (2013)

A Novel Epigenetic Phenotype Associated With the Most Aggressive Pathway of Bladder Tumor Progression
por: Vallot, Céline, et al.
Publicado: (2011)

The high protein expression of FOXO3, but not that of FOXO1, is associated with markers of good prognosis
por: Lallemand, François, et al.
Publicado: (2020)

A Case-Only Genome-Wide Interaction Study of Smoking and Bladder Cancer Risk: Results from the COBLAnCE Cohort
por: Karimi, Maryam, et al.
Publicado: (2023)

Prognostic value of a newly identified MALAT1 alternatively spliced transcript in breast cancer
por: Meseure, Didier, et al.
Publicado: (2016)

WWOX binds MERIT40 and modulates its function in homologous recombination, implications in breast cancer
por: Taouis, Karim, et al.
Publicado: (2023)

Integrated molecular and pharmacological characterization of patient-derived xenografts from bladder and ureteral cancers identifies new potential therapies
por: Lang, Hervé, et al.
Publicado: (2022)

BCG therapy downregulates HLA-I on malignant cells to subvert antitumor immune responses in bladder cancer
por: Rouanne, Mathieu, et al.
Publicado: (2022)

Gene Expression Profiling Reveals New Aspects of PIK3CA Mutation in ERalpha-Positive Breast Cancer: Major Implication of the Wnt Signaling Pathway
por: Cizkova, Magdalena, et al.
Publicado: (2010)

ERBB2 mutations associated with solid variant of high-grade invasive lobular breast carcinomas
por: Deniziaut, Gabrielle, et al.
Publicado: (2016)

Arpin downregulation in breast cancer is associated with poor prognosis
por: Lomakina, Maria E, et al.
Publicado: (2016)

Calcitonin gene–related peptide inhibits Langerhans cell–mediated HIV-1 transmission
por: Ganor, Yonatan, et al.
Publicado: (2013)

TYRO3 as a molecular target for growth inhibition and apoptosis induction in bladder cancer
por: Dufour, Florent, et al.
Publicado: (2019)

Lung Involvement in Chronic Schistosomiasis with Bladder Squamous Cell Carcinoma
por: Saade, Anastasia, et al.
Publicado: (2018)

Refining the use of neoadjuvant chemotherapy in locally advanced bladder cancer: from conviction to optimization
por: Culine, Stéphane, et al.
Publicado: (2018)

A Naive Lung Adenocarcinoma Harboring G1269A ALK Resistance Mutation
por: Trabelsi-Grati, Olfa, et al.
Publicado: (2020)

Cytidine deaminase activity increases in the blood of breast cancer patients
por: Buhagiar-Labarchède, Géraldine, et al.
Publicado: (2022)

Author Correction: Cytidine deaminase activity increases in the blood of breast cancer patients
por: Buhagiar‑Labarchède, Géraldine, et al.
Publicado: (2022)

Plekhs1 and Prdx3 are candidate genes responsible for mild hyperglycemia associated with obesity in a new animal model of F344-fa-nidd6 rat
por: KOTOH, Jun, et al.
Publicado: (2016)

PIK3CA mutation impact on survival in breast cancer patients and in ERα, PR and ERBB2-based subgroups
por: Cizkova, Magdalena, et al.
Publicado: (2012)

Biopathological Significance of PIWI–piRNA Pathway Deregulation in Invasive Breast Carcinomas
por: Meseure, Didier, et al.
Publicado: (2020)

Protein kinase D1 regulates ERα-positive breast cancer cell growth response to 17β-estradiol and contributes to poor prognosis in patients
por: Karam, Manale, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_12c9fap152lj6ie5hvlv6osit8